2013-09-13 10:21:34 - Recently published research from GlobalData, "Trout Capital LLC - Pharmaceuticals & Healthcare - Advisory Profile", is now available at Fast Market Research
Trout Capital LLC has created and implemented a business continuity plan (BCP) in an effort to mitigate the effects related to unforeseen business interruptions.
GlobalData's Trout Capital LLC - Pharmaceuticals & Healthcare - Advisory Profile provides an overview of the deals advised by Trout Capital LLC in the Pharmaceuticals and Healthcare market. The report is an essential source of information for Pharmaceuticals and Healthcare companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Trout Capital LLC's deals for the past five years segregated into year, deal type, segment and geography.
Full Report Details at
- www.fastmr.com/prod/652220_trout_capital_llc_pharmaceuticals_hea ..
* Provides essential information on the financial deals in which the firm provided
financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements
* Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information
* Analyzes the advisor's deals by year, deal type, segment and geography
* Provides detailed information on deal particulars, including information about other advisors involved in the deal
* Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed
* Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period
* Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company's key financial metrics and ratios (financials are available for major public companies).
Reasons to Get this Report
* Receive detailed information and evaluate the profile of a particular advisor in the market before considering for your business needs
* Peruse all the advisor's deals in the Industry market
* Access detailed information about the advisor's financial deals for the past five years that enable you to scrutinize the key deals, which have shaped investment policies
* Identify other potential advisors currently active in your industry, or industry that you wish to foray into
* Compare your advisory services vis-a-vis your competitors'
* Check and identify the advisor that suits your requirements, such as placement agents, book-runners and underwriters
* Examine the breakdown of deals by category and detailed information on major deals incorporated in the advisor's profile for your academic or business research needs and their suitability to your requirements.
Partial Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
Trout Capital LLC, Pharmaceuticals & Healthcare Deals Advised By Year, 2007 to YTD 2013
Trout Capital LLC, Pharmaceuticals & Healthcare Deals Advised By Type, 2007 to YTD 2013
Trout Capital LLC, Pharmaceuticals & Healthcare Deals Advised By Region, 2007 to YTD 2013
Trout Capital LLC, Pharmaceuticals & Healthcare Deals Advised By Sector, 2007 to YTD 2013
Trout Capital LLC, Pharmaceuticals & Healthcare Deals Advised Summary, 2007 to YTD 2013
Trout Capital LLC, Pharmaceuticals & Healthcare, Deal Details
Thomson Reuters Acquires GeneGo
Intendis Acquires Two Dermatology Products From SkinMedica
DUSA Pharma Completes Private Placement Of US$11 Million
Keryx Biopharma Completes Public Offering Of Shares For US$80 Million
Inhibitex Completes An Underwritten Public Offering For US$54.1 Million
Anthera Pharma Completes Public Offering Of Common Stock For US$40 Million
BioSante Pharma Completes Registered Direct Offering Of Units For US$25.1 Million
BioSante Pharma Completes Registered Direct Offering Of US$15 Million
AVANIR Pharma Completes Public Offering Of US$11 Million
Titan Pharma Completes Private Placement Of US$1 Million
Arrowhead Research Completes Private Placement Of Preferred Shares For US$10 Million
Cell Therapeutics Completes Private Placement Of Series 13 Preferred Stock For US$30 Million
Cell Therapeutics Completes Private Placement Of Series 7 Preferred Stock For US$21 Million
VIVUS Completes Public Offering Of US$109 Million
Pharmaxis Completes Private Placement Of US$11 Million
Arrowhead Research Completes Private Placement Of Shares For US$26 Million
Genetic Technologies Completes Private Placement Of Shares For US$12.6 Million
AVANIR Pharma Completes An Underwritten Public Offering Of Its Common Stock For US$88 Million
Cell Therapeutics Completes Private Placement Of Preferred Stock For US$30 Million
Pharmasset Completes Registered Direct Public Offering Of US$26 Million
Avalon Pharma Completes Private Placement Of US$10 Million
Cell Therapeutics Completes Private Placement Of Preferred Stock For US$20 Million
VIVUS Completes Registered Direct Offering Of Common Stock For US$65 Million
Vasogen Completes Private Placement Of US$15.98 Million
Full Table of Contents is available at:
GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.